PECAM1 and neoplasm: Both αSMA and CD31 expression increased by 30% and 25%, respectively, in livers collected from mice bearing sICAM-1 treated tumor cells, indicating a higher number of activated HSCs and angiogenic LSECs in tumor foci originated from sICAM-1 treated tumor cells (Fig. 5B,C).